Canon Redesigns OCT Averaging Technology to Better Visualise Retinal Disease, to be Launched at ESCRS
LONDON, October 2017 - Canon Europe will demonstrate its commitment to offering ground-breaking diagnostic efficiency through its Medical Imaging Solutions with the launch of its new software for OCT Angiography (OCT-A) technology at the XXXV congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Lisbon, Portugal (7-11 October 2017).
Image Courtesy Canon Europe
The software, designed for use with the OCT-HS100, will provide eye care professionals with enhanced digital retinal imaging. This new software version’s key feature includes the introduction of the new Flow Fusion Technology for OCT-A. This addition uses the unique 3 micron optical resolution of the OCT-HS100 to deliver unsurpassed 3-D imaging with high contrast, and more efficient data analysis, giving eye care practitioners access to further diagnostic information leading to better informed diagnoses.
Tom Jacques, Director of Canon Medical Imaging Group (MIG), comments: “Canon has been at the forefront of innovation in ophthalmic diagnostic equipment design since 1976. Our motivation is to improve patient care by providing health professionals with an excellent user experience and we are delighted to now introduce these new functionalities that will contribute to the early diagnosis of retinal diseases by eye care professionals.”
Improved functions for OCT and OCT Angiography include:
- Flow Fusion Technology which utilises real time tracking control and a special repeat acquisition mode
to capture consecutive scans at a precise position. Combining the data of multiple OCT-A acquisitions to greatly improve image quality
- More detailed visualisation of the superficial, deeper, inner retina, mid-retina, outer retina and chorio capillaries
- Image quality improvement, allowing the detection of weak blood flow signals which would otherwise have been excluded from examination data
- Projection Artifact Removal tool, for enhanced detection of Choroidal Neo Vascularisation (CNV), a leading cause of visual loss
- A new optional Mosaic function that can create large panoramic OCT-A images up to 17.5 mm wide, requiring no more than a quick 5 single wide scans
In addition to its new software version, visitors to Canon Europe’s stand at ESCRS will also be offered best clinical practice demonstrations by industry experts Dr. Sal Rassam, MD DO FRCOphth, Consultant Ophthalmic Surgeon of Panacea Medical Center, UK, and Dr. Alejandro Cervino, PhD, Associate Professor, Department of Optics & Optometry & Vision Science, University of Valencia, Spain.
To sign up for a demonstration, or to find out more about Canon Europe’s eye care solutions please visit booth P1114 at ESCRS or go to: https://www.canon-europe.com/escrs/
For more information about Canon’s healthcare solutions and services go to: http://www.canon-europe.com/medical/
About Canon Europe
Canon Europe is the EMEA arm of Canon Inc., a global provider of imaging technologies and services, and one of the world’s most well-recognised and loved brands. Canon Europe has operations in around 120 countries, employs approximately 19,000 people across the region, and contributes about a third of Canon’s global revenues annually.
Founded in 1937, Canon has been a leading name in imagery for the past 80 years, and is dedicated to helping people constantly re-imagine what is possible through imaging. From cameras to commercial printers, business consultancy to healthcare technologies, Canon enriches lives and businesses through imaging innovation.
Canon is growing the positive power of imaging technology and services. By delivering social and environmental benefits through our people and products, we are powerfully demonstrating our commitment to our philosophy of Kyosei: living and working together for the common good.
Further information about Canon Europe is available at: www.canon-europe.com
